Product Code: ETC191556 | Publication Date: Jul 2023 | Updated Date: Jan 2024 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 40 | No. of Tables: 7 | |
Intravenous iron drugs are used to treat iron deficiency anemia, which is a common condition in India. Iron deficiency is caused by inadequate dietary intake of iron or impaired absorption of the mineral from foods. Intravenous iron drugs can help replenish the depleted stores of iron and restore normal levels in blood tests.
The primary driver for growth in the market for intravenous iron drugs is increasing awareness about the importance of maintaining adequate levels of hemoglobin and other essential minerals such as iron among healthcare professionals and consumers alike. This has led to increased demand for these products, which has propelled the market???s growth over recent years. Additionally, technological advancements have enabled manufacturers to develop more effective formulations that are better absorbed into human body systems, leading to greater efficacy rates and higher customer satisfaction scores than ever before. Furthermore, rising prevalence of anemia due to malnutrition across India has further fueled demand for IV-iron drugs within this region.
A major challenge facing manufacturers operating within this space include stringent regulations governing production processes coupled with high costs associated with product development and marketing efforts needed in order to stay successful within this highly competitive environment. Moreover , generic competition has been on rise lately , resulting in reduced profit margins. In addition , there exists lack of accessibilty & affordability issues amongst rural population , adversely impacting adoption rate.
Some key players operating in India IV-Iron Drugs Market include Cipla Ltd., Sun Pharma (Ranbaxy), Wockhardt Ltd., Natco Pharma Limited, Lupin Pharmaceuticals Inc., Cadila Healthcare Limited etc..
Due to Covid -19 pandemic situation leading several disruptions across supply chain network including production & distribution activities , it`s estimated that India IV-Iron drug market shall witness decelerated growth rate during 2020 -21 period compared earlier trend prior COVID crisis. Also emergence new safety protocols particularly related social distancing & hygiene measures may lead certain challenges while manufacturing operations. However industry still expects recovery post 2021 once economic climate stabilizes accordingly
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Intravenous Iron Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Intravenous Iron Drugs Market Revenues & Volume, 2020 & 2030F |
3.3 India Intravenous Iron Drugs Market - Industry Life Cycle |
3.4 India Intravenous Iron Drugs Market - Porter's Five Forces |
3.5 India Intravenous Iron Drugs Market Revenues & Volume Share, By By Product, 2020 & 2030F |
3.6 India Intravenous Iron Drugs Market Revenues & Volume Share, By By Application, 2020 & 2030F |
4 India Intravenous Iron Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India Intravenous Iron Drugs Market Trends |
6 India Intravenous Iron Drugs Market, By Types |
6.1 India Intravenous Iron Drugs Market, By By Product |
6.1.1 Overview and Analysis |
6.1.2 India Intravenous Iron Drugs Market Revenues & Volume, By By Product, 2020-2030F |
6.1.3 India Intravenous Iron Drugs Market Revenues & Volume, By Iron Dextran, 2020-2030F |
6.1.4 India Intravenous Iron Drugs Market Revenues & Volume, By Iron Sucrose, 2020-2030F |
6.1.5 India Intravenous Iron Drugs Market Revenues & Volume, By Ferric Carboxymaltose, 2020-2030F |
6.1.6 India Intravenous Iron Drugs Market Revenues & Volume, By Others, 2020-2030F |
6.2 India Intravenous Iron Drugs Market, By By Application |
6.2.1 Overview and Analysis |
6.2.2 India Intravenous Iron Drugs Market Revenues & Volume, By Chronic Kidney Disease, 2020-2030F |
6.2.3 India Intravenous Iron Drugs Market Revenues & Volume, By Inflammatory Bowel Disease, 2020-2030F |
6.2.4 India Intravenous Iron Drugs Market Revenues & Volume, By Cancer, 2020-2030F |
6.2.5 India Intravenous Iron Drugs Market Revenues & Volume, By Others, 2020-2030F |
7 India Intravenous Iron Drugs Market Import-Export Trade Statistics |
7.1 India Intravenous Iron Drugs Market Export to Major Countries |
7.2 India Intravenous Iron Drugs Market Imports from Major Countries |
8 India Intravenous Iron Drugs Market Key Performance Indicators |
9 India Intravenous Iron Drugs Market - Opportunity Assessment |
9.1 India Intravenous Iron Drugs Market Opportunity Assessment, By By Product, 2020 & 2030F |
9.2 India Intravenous Iron Drugs Market Opportunity Assessment, By By Application, 2020 & 2030F |
10 India Intravenous Iron Drugs Market - Competitive Landscape |
10.1 India Intravenous Iron Drugs Market Revenue Share, By Companies, 2023 |
10.2 India Intravenous Iron Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |